Home | Research | Publications | Teaching | Awards & Honours | Selected Invited Presentations

Roxana Moslehi, B.Sc.(Honours), M.Sc., Ph.D.

  • Moslehi R, Freedman E, Zeinomar N, Veneroso C, and Levine PH.
    Importance of Hereditary and Selected Environmental Risk Factors in the Etiology of Inflammatory Breast Cancer: A Case-Comparison Study.
    BMC Cancer. 2016 May 26;16(1):334. doi: 10.1186/s12885-016-2369-z

  • Moslehi R, Ambroggio X, Nagarajan V, Kumar A, and Dzutsev A.
    Nucleotide Excision Repair/Transcription Gene Defects in the Fetus and Impaired TFIIH-Mediated Function in Transcription in Placenta Leading to Preeclampsia.
    BMC Genomics 2014; 15:373; DOI: 10.1186/1471-2164-15-373

  • Moslehi R, Mills JL, Signore C, Kumar A, Ambroggio X, and Dzutsev A.
    Integrative transcriptome analysis reveals dysregulation of canonical cancer molecular pathways in placenta leading to preeclampsia.
    Nature Scientific Reports 2013 3, 2407; DOI:10.1038/srep02047

  • Zeinomar N. and Moslehi R.
    The Effectiveness of a Community-Based Breast Cancer Education Intervention in the New York State Capital Region.
    Journal of Cancer Education 2013 28:466-473; DOI 10.1007/s13187-013-0488-7

  • Chen L, Bell EM, Browne M, Druschel C, Romitti P, Schmidt R, Burns T, Moslehi R, Olney RS and the National Birth Defects Prevention Study.
    Maternal Caffeine Consumption and Risk of Congenital Limb Deficiencies.
    Birth Defects Research Part A: Clinical and Molecular Teratology 2012; 94 (12):1033-43

  • Moslehi R, Kumar A, Mills JL, Ambroggio X, Signore C and Dzutsev A.
    Phenotype-Specific Adverse Effects of XPD Mutations on Human Prenatal Development Implicate Impairment of TFIIH-Mediated Functions in Placenta.
    European Journal of Human Genetics 2012; 20: 626-631

  • Deborah Tamura, Melissa Merideth, John J. DiGiovanna, Xiaolong Zhou, Margaret A. Tucker, Alisa M. Goldstein, Brian P. Brooks, Sikandar G. Khan1, Kyu-Seon Oh, Takahiro Ueda, Jennifer Boyle, Roxana Moslehi and Kenneth H. Kraemer
    High-risk pregnancy and neonatal complications in the DNA repair and transcription disorder trichothiodystrophy: report of 27 affected pregnancies
    Prenatal Diagnosis 2011; 31(11): 1046-1053

  • Moslehi R, Coles FB, Schymura MJ.
    Descriptive Epidemiology of Ophthalmic and Ocular Adnexal Non-Hodgkin Lymphoma.
    Expert Reviews of Ophthalmology 2011; 6(2): 175-180

  • Moslehi R, Schymura MJ, Nayak S and Coles FB.
    Ocular Adnexal Non-Hodgkin Lymphoma: A Review of Epidemiology and Risk Factors.
    Expert Review of Ophthalmology 2011; 6(2): 181-193

  • Moslehi R, Signore C, Tamura D, Mills JL, Digiovanna JJ, Tucker MA, Troendle J, Ueda T, Boyle J, Khan SG, Oh KS, Goldstein AM, Kraemer KH.
    Adverse effects of trichothiodystrophy DNA repair and transcription gene disorder on human fetal development.
    Clinical Genetics 2010; 77(4): 365-373

  • Moslehi R, Singh R, Lessner L, Friedman JM.
    Impact of BRCA mutations on female fertility and offspring sex ratio
    Am J Hum Biol. 2010 Mar;22(2):201-5 PMID: 19642207

  • Tan X, Moslehi R, Han W, and Spivack S.
    Haplotype-tagging single nucleotide polymorphisms in the GSTP1 gene promoter and susceptibility to lung cancer.
    Cancer Detect Prev. 2009;32(5-6):403-15. Epub 2009 Mar 17 PMID: 19282111

  • Kuznetsov I.B., McDuffie M, Moslehi R.
    A web server for inferring the human N-acetyltransferase-2 (NAT2) enzymatic phenotype from NAT2 genotype.
    Bioinformatics. 2009 May 1;25(9):1185-6. Epub 2009 Mar 4 PMID: 19261719

  • Wang Y, Zhang L, Moslehi R, Ma J, Pan K, Zhou T, Liu W, Brown LM, Hu Y, Pee D, Gail MH, You W.
    Long-term garlic or micronutrient supplementation, but not anti-Helicobacter pylori therapy, increases serum folate or glutathione without affecting serum vitamin B-12 or homocysteine in a rural Chinese population.
    J Nutr. 2009 Jan;139(1):106-12. Epub 2008 Dec 3. PMID: 19056661

  • Ahn J, Moslehi R, Weinstein SJ, Snyder K, Virtamo J, Albanes D.
    Family history of prostate cancer and prostate cancer risk in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study.
    Int J Cancer. 2008 Sep 1;123(5):1154-9. PMID: 18546266

  • Chatterjee N, Kalaylioglu Z, Moslehi R, et al.
    Powerful multilocus Tests of Genetic Association in the presence of gene-gene and gene-environment interactions.
    Am J Hum Genet 2006; 79(6):1002-16

  • Moslehi R, Chatterjee N, Church TR, et al.
    Cigarette smoking, N-acetyltransferase genes and the risk of advanced colorectal adenoma.
    Pharmacogenomics 2006; 7(6):819-29

  • Zhang L, Gail MH, Wang Y, Brown LM, Pan K, Ma J, Amagase H, You W, Moslehi R.
    A randomized factorial study of the effects of long-term garlic and micronutrient supplementation and of 2-week antibiotic treatment for Helicobacter pylori infection on serum cholesterol and lipoproteins.
    Am J Clin Nutr 2006; 84(4):912-9

  • Moslehi R, Devesa S, Schairer C, Fraumeni JF.
    Rapidly increasing incidence of ocular (eye and adnexa) non-Hodgkin lymphoma.
    J Natl Cancer Inst 2006; 98: 936-939

  • Goldin L, Camp N, Keen K, Martin L, Moslehi R, Ghosh S et al.
    GAW13 Analyses of Obesity, Diabetes, and Lipid Phenotypes.
    Genet Epidemiol 2003; 25(1):S78-S89

  • Cass I, Baldwin R, Varkey T, Moslehi R, Narod S, Karlan B.
    Improved survival in women with BRCA-associated ovarian cancer.
    Cancer 2003; 97,9:2187-2195

  • Modugno F, Moslehi R, Ness R, Nelson D, Belle, S, Kant J et al.
    Reproductive factors and cancer risk in Jewish BRCA1 and BRCA2 mutation carriers.
    Cancer Causes and Controls 2003; 14:439-446

  • Moslehi R, Goldstein A, Beerman M, Goldin L, Bergen A.
    A genomewide linkage scan for BMI on Framingham heart study families.
    BMC Genet 2003, 4(Suppl 1):S97

  • Moslehi R, Kariminejad MH, Ghaffari, V, Narod S.
    Analysis of BRCA1 and BRCA2 mutations in an Iranian family with hereditary breast and ovarian cancer syndrome.
    Am J Med Genet 2003; 117A:304-305

  • Runnebaum I, Wang-Gorhrke S, Vespirini D, Kreienberg R, Lynch H, Moslehi R, Ghadirian P, et al.
    Progesterone receptor variant increases ovarian cancer risk in BRCA1 and BRCA2 mutations carriers who were never exposed to oral contraceptives.
    Pharmacogenetics 2001; 11:635-638.

  • Moslehi R, Chu W, Karlan B, Fishman D, Risch H, Fields A, Smotkin D, Ben-David Y, Rosenblatt J, Russo D, Schwartz P, Tung N, Warner E, Rosen B, Friedman J, Brunet JS, Narod SA.
    BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer.
    Am J Hum Genet 2000; 66(4):1259-1272.

  • Moslehi R, Russo D, Phelan C, Jack E, Antman K, Narod S.
    An unaffected individual from a breast/ovarian cancer family with germline mutations in both BRCA1 and BRCA2.
    Clin Genet 2000;57(1):70-73.

  • Wang-Gohrke S, Weikel W, Risch H, Vesprini D, Abrahamson J, Lerman C, Godwin A, Moslehi R, Olipade O, Brunet JS, Stickeler E, Kieback DG, Kreienberg R, Weber B, Narod SA, Runnebaum IBl.
    Intron variants of the p53 gene are associated with increased risk for ovarian cancer but not in carriers of BRCA1 or BRCA2 germline mutations.
    Br J Cancer 1999;81(1):179-83.

  • Warner E, Foulkes W, Goodwin PA, Meschino W, Blondal J, Patteron C, Ozce KH, Goss P, Allingham-Hawkins D, Hamel N, Di Prospero L, Contiga V, Serruya C, Klein M, Moslehi R et al.
    Prevalence and penetrance of BRCA1 and BRCA2 mutations in unselected Ashkenazi Jewish women with breast cancer.
    J Natl Cancer Inst 1999; 91:(14):1241-1247.

  • Brunet JS, Ghadirian P, Rebbeck TR, Lerman C, Garber JE, Tonin PN, Abrahamson J, Foulkes WD, Daly M, Wagner-Costalas J, Godwin A, Olopade OI, Moslehi R Liede A, Futreal PA, Weber BL, Lenoir GM, Lynch HT, Narod SA.
    Effect of smoking on breast cancer in carriers of mutant BRCA1 or BRCA2 genes.
    J Natl Cancer Inst 1998;90(10):761-766.

  • Liede A, Metcalf K, Offit K, Brown K, Miller S, Narod S, Moslehi R.
    A family with three germline mutations in BRCA1 and BRCA2.
    Clin Genet 1998;54:215-218.

  • Narod S, Risch H, Moslehi R, Dorum A, Neuhausen S, Olsson H, Provencher D, Radice P, et al.
    Oral contraceptive use reduces the risk of hereditary ovarian cancer.
    N Engl J Med 1998;339(7):424-428.

  • Abrahamson J, Moslehi R, Vesprini D, Karlan B, Fishman D, Smotkin D, Ben David Y, Biran H, Fields A, Brunet JS, Narod SA.
    No association of the I1307K APC allele with ovarian cancer risk in Ashkenazi Jews.
    Cancer Res 1998;58:2919-2922.

  • Moslehi R, Solehdin F, Malik I, Narod S.
    Analysis of BRCA1 mutations in a Pakistani family with hereditary breast and ovarian cancer syndrome.
    Am J Med Genet 1998;78(4):386-387.

  • Moslehi R, Langlois S, Yam I, Friedman JM.
    Linkage of malignant hyperthermia and hyperkalemic periodic paralysis to the adult skeletal muscle sodium channel (SCN4A) gene in a large pedigree.
    Am J Med Genet 1998;76:21-27.

  • Phelan C, Lancaster J, Tonin P, Gumbs C, Cochran C, Carter R, Ghadirian P, Perret C, Moslehi R, Dion F, Faucher MC, Dole K, Karimi S, Foulkes W, Lounis H, Warner E, Goss P, Anderson D, Larsson C, Narod SA, Futreal PA.
    Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer families.
    Nat Genet 1996;13(1):120-122.

  • Tonin P, Moslehi R, Green R, Rosen B, Cole D, Boyd N, Cutler C, Margolese R, Carter R, McGillivray B, et al.
    Linkage analysis of 26 Canadian breast and breast-ovarian cancer families.
    Hum Genet 1995;95(5):545-550.

  • Narod S, Ford D, Devilee P, Barkardottir R, Lynch H, Smith S, Ponder B., Moslehi R et al.
    An evaluation of genetic heterogeneity in 145 breast-cancer ovarian-cancer families.
    Am J Hum Genet 1995; 56(1):254-264

  • Narod S, Goldgar D, Cannon-Albright L, Weber B, Moslehi R, Ives E, Lenoir G, Lynch H.
    Risk modifiers in carriers of BRCA1 mutations.
    Int J Cancer 1995; 64(6):394-398.